Malta - Tiếng Anh - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - chromic chloride, copper chloride, ferric chloride, manganese chloride, potassium iodide, sodium fluoride, sodium molybdate, sodium selenite, zinc chloride - concentrate for solution for infusion - chromic chloride 5.33 µg copper chloride 340 µg ferric chloride 540 µg manganese chloride 99 µg potassium iodide 16.6 µg sodium fluoride 210 µg sodium molybdate 4.85 µg sodium selenite 10.5 µg zinc chloride 1.36 mg - blood substitutes and perfusion solutions

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

remedyrepack inc. - ziprasidone hydrochloride (unii: 216x081oru) (ziprasidone - unii:6uka5vej6x) - ziprasidone 80 mg - ziprasidone hydrochloride capsule is an atypical antipsychotic. in choosing among treatments, prescribers should be aware of the capacity of ziprasidone hydrochloride capsule to prolong the qt interval and may consider the use of other drugs first (5.2) ziprasidone hydrochloride capsule is indicated as an oral formulation for the treatment of schizophrenia. (1.1) adults: efficacy was established in 4 to 6 week trials and one maintenance trial in adult patients with schizophrenia  (14.1) because of ziprasidone's dose-related prolongation of the qt interval and the known association of fatal arrhythmias with qt prolongation by some other drugs, ziprasidone is contraindicated: - in patients with a known history of qt prolongation (including congenital long qt syndrome) - in patients with recent acute myocardial infarction - in patients with uncompensated heart failure pharmacokinetic/pharmacodynamic studies between ziprasidone and other drugs that prolong the qt interval have not been performed. an additive eff

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - chromic chloride.6h2o; copper chloride.2h2o; ferric chloride.6h2o; manganese chloride.4h2o; potassium iodide; sodium fluoride; sodium molybdate.2h2o; sodium selenite anhydrous; zinc chloride - injection - 5.33 mcg/ml - chromic chloride.6h2o 5.33 mcg/ml; copper chloride.2h2o 0.34 mg/ml; ferric chloride.6h2o 0.54 mg/ml; manganese chloride.4h2o 99 mcg/ml; potassium iodide 16.6 mcg/ml; sodium fluoride 0.21 mg/ml; sodium molybdate.2h2o 4.85 mcg/ml; sodium selenite anhydrous 6.9 mcg/ml; zinc chloride 1.36 mg/ml

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - chromic chloride hexahydrate; cupric chloride dihydrate ; ferric chloride hexahydrate ; manganese chloride tetrahydrate ; potassium iodide ; sodium fluoride; sodium molybdate dihydrate ; sodium selenite anhydrous ; zinc chloride - concentrate for soln for inf - n/a - electrolytes in combination with other drugs - electrolytes in combination with other drugs - to meet basal to moderately increased requirements of trace elements in intravenous nutrition

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - chromic chloride hexahydrate; copper chloride dihydrate; ferric chloride hexahydrate; manganese chloride tetrahydrate; potassium iodide; sodium fluoride; sodium molybdate dihydrate; sodium selenite anhydrous; zinc chloride - concentrate for solution for infusion - electrolyte solutions; electrolytes in combination with other drugs

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

avkare, inc. - moexipril hydrochloride (unii: q1umg3uh45) (moexiprilat - unii:h3753190js), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - moexipril hydrochloride 7.5 mg - moexipril hydrochloride and hydrochlorothiazide tablets usp are indicated for treatment of patients with hypertension. this fixed combination is not indicated for the initial therapy of hypertension (see dosage and administration). in using moexipril hydrochloride and hydrochlorothiazide tablets usp, consideration should be given to the fact that another ace inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that moexipril hydrochloride and hydrochlorothiazide tablets usp do not have a similar risk (see warnings , neutropenia/agranulocytosis ). in addition, ace inhibitors, for which adequate data are available, cause a higher rate of angioedema in black than in nonblack patients (see warnings , angioedema ). moexipril hydrochloride and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitiv

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - cevimeline hydrochloride (unii: p81q6v85np) (cevimeline - unii:k9v0cdq56e) - cevimeline hydrochloride anhydrous 30 mg - cevimeline hydrochloride is indicated for the treatment of symptoms of dry mouth in patients with sjögren’s syndrome. cevimeline hydrochloride is contraindicated in patients with uncontrolled asthma, known hypersensitivity to cevimeline, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle-closure) glaucoma.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - moexipril hydrochloride (unii: q1umg3uh45) (moexiprilat - unii:h3753190js), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - moexipril hydrochloride 7.5 mg - moexipril hydrochloride and hydrochlorothiazide tablets are indicated for treatment of patients with hypertension. this fixed combination is not indicated for the initial therapy of hypertension (see dosage and administration). in using moexipril hydrochloride and hydrochlorothiazide tablets, consideration should be given to the fact that another ace inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that moexipril hydrochloride and hydrochlorothiazide tablets do not have a similar risk (see warnings, neutropenia/agranulocytosis ). in addition, ace inhibitors, for which adequate data are available, cause a higher rate of angioedema in black than in nonblack patients (see warnings, angioedema ). moexipril hydrochloride and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitive to any component of this product and in patients with a history of angioedema related to prev

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - moexipril hydrochloride (unii: q1umg3uh45) (moexiprilat - unii:h3753190js), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - moexipril hydrochloride 7.5 mg - moexipril hydrochloride and hydrochlorothiazide tablets usp are indicated for treatment of patients with hypertension. this fixed combination is not indicated for the initial therapy of hypertension (see dosage and administration). in using moexipril hydrochloride and hydrochlorothiazide tablets usp, consideration should be given to the fact that another ace inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that moexipril hydrochloride and hydrochlorothiazide tablets usp do not have a similar risk (see warnings , neutropenia/agranulocytosis ). in addition, ace inhibitors, for which adequate data are available, cause a higher rate of angioedema in black than in nonblack patients (see warnings , angioedema ). moexipril hydrochloride and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitive to any component of this product and in patients with a history of angioedema r

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

unit dose services - ziprasidone hydrochloride (unii: 216x081oru) (ziprasidone - unii:6uka5vej6x) - ziprasidone 20 mg - ziprasidone hydrochloride capsules are indicated for the treatment of schizophrenia. when deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone's greater capacity to prolong the qt/qtc interval compared to several other antipsychotic drugs [see warnings and precautions (5.2)]. prolongation of the qtc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. in many cases this would lead to the conclusion that other drugs should be tried first. whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see warnings and precautions (5.2)]. ziprasidone hydrochloride capsules are indicated for the treatment of schizophrenia. the efficacy of oral ziprasidone was established in four short-term (4- and 6-week) controlled trials of adult schizophrenic inpatien